The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients.
You H, Jin S, Wu C, Wang Q, Yan S, Yao W, Shi X, Shang J, Yan L, Yao Y, Wang J, Wang P, Pan J, Wu D, Fu C.
You H, et al. Among authors: yan l, yan s.
Front Oncol. 2022 Oct 7;12:938392. doi: 10.3389/fonc.2022.938392. eCollection 2022.
Front Oncol. 2022.
PMID: 36276097
Free PMC article.